CEO of BioMarin Pharmaceutical Inc. (BMRN, Financial) Jean Jacques Bienaime sells 4,000 shares of BMRN on 08/10/2009 at an average price of $15.95 a share.
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating life-threatening chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin\'s lead product BM101 for the treatment of mucopolysaccharidosis-I or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans. BioMarin Pharmaceutical Inc. has a market cap of $1.57 billion; its shares were traded at around $15.67 with a P/E ratio of 130.6 and P/S ratio of 5.2.
BMRN is in the portfolios of PRIMECAP Management.
Recent Trades of BioMarin Pharmaceutical Inc. by CEO:
Recent Trades of BioMarin Pharmaceutical Inc. by Directors and Officers:
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating life-threatening chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin\'s lead product BM101 for the treatment of mucopolysaccharidosis-I or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans. BioMarin Pharmaceutical Inc. has a market cap of $1.57 billion; its shares were traded at around $15.67 with a P/E ratio of 130.6 and P/S ratio of 5.2.
BMRN is in the portfolios of PRIMECAP Management.
Recent Trades of BioMarin Pharmaceutical Inc. by CEO:
- Buy: CEO Jean Jacques Bienaime bought 1,500 shares of BMRN stock on 06/12/2009 at the average price of $14.52; the price of the stock has increased by 7.92% since.
Recent Trades of BioMarin Pharmaceutical Inc. by Directors and Officers:
- Buy: Director Richard A Meier bought 2,000 shares of BMRN stock on 06/05/2009 at the average price of $13.7; the price of the stock has increased by 14.38% since.
- Buy: Director Richard A Meier bought 1,000 more shares of BMRN stock on 03/13/2009 at the average price of $11.45; the price of the stock has increased by 36.86% since.
- Buy: Director Joseph Iii Klein bought 5,000 shares of BMRN stock on 03/05/2009 at the average price of $10.07; the price of the stock has increased by 55.61% since.
- Buy: Director Jean Jacques Bienaime bought 1,000 shares of BMRN stock on 03/05/2009 at the average price of $10.04; the price of the stock has increased by 56.08% since.
- Buy: Director Richard A Meier bought 2,000 shares of BMRN stock on 03/03/2009 at the average price of $10.93; the price of the stock has increased by 43.37% since.
